Cargando…
Putative markers for the detection of early-stage bladder cancer selected by urine metabolomics
BACKGROUND: Early detection of bladder cancer remains challenging because patients with early-stage bladder cancer usually have no incentive to take cytology or cystoscopy tests if they are asymptomatic. Our goal is to find non-invasive marker candidates that may help us gain insight into the metabo...
Autores principales: | Lin, Jia-You, Juo, Bao-Rong, Yeh, Yu-Hsuan, Fu, Shu-Hsuan, Chen, Yi-Ting, Chen, Chien-Lun, Wu, Kun-Pin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8180080/ https://www.ncbi.nlm.nih.gov/pubmed/34090341 http://dx.doi.org/10.1186/s12859-021-04235-z |
Ejemplares similares
-
Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics
por: Shao, Chi-Hung, et al.
Publicado: (2017) -
Targeting amine- and phenol-containing metabolites in urine by dansylation isotope labeling and liquid chromatography mass spectrometry for evaluation of bladder cancer biomarkers
por: Chen, Yi-Ting, et al.
Publicado: (2019) -
Urinary Metabolomic Analysis of Prostate Cancer by UPLC-FTMS and UPLC-Ion Trap MS(n)
por: Chen, Chien-Lun, et al.
Publicado: (2023) -
Discovery of Volatile Biomarkers for Bladder Cancer Detection and Staging through Urine Metabolomics
por: Pinto, Joana, et al.
Publicado: (2021) -
Bladder cancer recurrence surveillance by urine metabolomics analysis
por: Loras, A., et al.
Publicado: (2018)